Stem cell biotech firm Geron quits field
Wednesday, November 16, 2011 - 08:31
in Mathematics & Economics
Geron Corp. is exiting the field it pioneered in a calculated business move that underscores the long, costly path embryonic stem cells face to become real-world products.